Lagophthalmos successfully treated by high pretarsal placement

Article

Gold weights inserted using a high pretarsal placement can treat lagophthalmos.

Gold weights inserted using a high pretarsal placement can treat lagophthalmos, discovered a study in the British Journal of Ophthalmology.

A retrospective review, conducted by Dr Raman Malhotra and his team, Corneo Plastic Unit, Queen Victoria Hospital NHS Trust, East Grinstead, Sussex, UK, included 107 consecutive gold weight implants in 95 lagophthalmos patients studied over a 5 year period.

Gold weights were implanted using a combination of high pretarsal placement, levator recession and fixation. Revision surgery for the gold implants included repositioning, removing or exchanging the implants.

Photographs of each case were taken preoperatively and 6 months postoperatively in order to conduct a blind assessment of eyelid parameters.

Of the patients studied, five eyes needed three further revisions each. The indications for these revisions included 15 eyelids prominent implants, poor eyelid contour in 14 eyelids, extrusion in two eyelids and persistent erythema in eight eyelids. The revisions included six platinum chain exchanges, three replacements, eight repositioned implants and four removals.

Revision procedures were mostly completed within 12 months, with a complication rate of 1 in 6. The most frequent indications for revisions were unsatisfactory cosmesis from prominence of implant and poor eyelid contour.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.